Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT05761977 · UNKNOWN
Trial details
- NCT number
- NCT05761977
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-31
- Primary completion
- 2023-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.